Pykon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 1244.38%
(FY 2023)
- Profit 13.71%
(FY 2023)
- Ebitda 90.22%
(FY 2023)
- Net Worth -105.35%
(FY 2023)
- Total Assets 1.91%
(FY 2023)
About Pykon Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kapil Jindal and Abhishek Jindal serve as directors at the Company.
- CIN/LLPIN
U24290HR2021PTC097227
- Company No.
097227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pykon Healthcare Private Limited offer?
Pykon Healthcare Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Common Disease Medicines, Antihistamines, Osteoporosis Medications, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Pykon Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Jindal  | Director | 26-Aug-2021 | Current |
| Kapil Jindal | Director | 26-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Pykon Healthcare.
Pykon Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1244.38% increase. The company also saw a substantial improvement in profitability, with a 13.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 105.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pykon Healthcare?
In 2023, Pykon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pykon Healthcare?
Pykon Healthcare has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pykon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pykon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
